Related Experiment Video
Updated: Dec 21, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration
Abhishek Jauhari1,2,3, Tanisha Singh1,3, Saumya Mishra1,2
1Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow 226001, Uttar Pradesh, India.
Abstract:
Mitochondrial dysfunction is a common cause in pathophysiology of different neurodegenerative diseases. Elimination of dysfunctional and damaged mitochondria is a key requirement for maintaining homeostasis and bioenergetics of degenerating neurons. Using global microRNA (miRNA) profiling in a systemic rotenone model of Parkinson's disease, we have identified miR-146a as upmost-regulated miRNA, which is known as inflammation regulatory miRNA. Here, we report the role of activated nuclear factor kappa beta (NF-kβ) in miR-146a-mediated downregulation of Parkin protein, which inhibits clearance of damaged mitochondria and induces neurodegeneration. Our studies have shown that 4-week rotenone exposure (2.5 mg/kg b.wt) induced oxidative imbalance-mediated NF-kβ activation in 1-year-old rat's brain. Activated NF-kβ binds in promoter region of miR-146a gene and induces its transcription, which downregulates levels of Parkin protein. Decreased amount of Parkin protein results in accumulation of damaged and dysfunctional mitochondria, which further promotes the generation of reactive oxygen species in degenerating neurons. In conclusion, our studies have identified direct role of NF-kβ-mediated upregulation of miR-146a in regulating mitophagy through inhibition of the Parkin gene.
Insights
Parkinson's disease involves mitochondrial issues. This study reveals how NF-κβ activation upregulates miR-146a, downregulating Parkin protein, impairing mitophagy, and worsening neurodegeneration.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mitochondrial dysfunction is central to neurodegenerative diseases like Parkinson's.
- Efficient removal of damaged mitochondria (mitophagy) is crucial for neuronal health.
Purpose of the Study:
- To investigate the role of microRNA-146a (miR-146a) in rotenone-induced Parkinson's disease model.
- To elucidate the mechanism linking nuclear factor kappa beta (NF-κβ), miR-146a, and Parkin in neurodegeneration.
Main Methods:
- Utilized a systemic rotenone exposure model in rats to induce Parkinson's-like pathology.
- Performed global microRNA profiling to identify differentially expressed miRNAs.
- Investigated the binding of NF-κβ to the miR-146a gene promoter and its effect on Parkin protein levels.
Main Results:
- Rotenone exposure upregulated miR-146a, a known inflammation regulator.
- Activated NF-κβ was found to bind the miR-146a promoter, increasing its transcription.
- This led to decreased Parkin protein, inhibiting mitophagy and increasing reactive oxygen species.
Conclusions:
- Identified a novel NF-κβ-miR-146a pathway contributing to Parkinson's disease pathogenesis.
- This pathway impairs mitophagy by downregulating Parkin, leading to mitochondrial accumulation and neurodegeneration.
More Related Videos
11:53Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System
Published on: October 26, 2010
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview